Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France
NCT01238809 · Status: WITHDRAWN · Type: OBSERVATIONAL · Enrollment: 7300
Last updated 2011-06-08
Summary
The purpose of this study is to assess in general population low-dose aspirin and gastroprotective agent compliance and reasons for bad compliance
Conditions
- Self-administered Questionnaire to Patients
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Mrs Genevieve BONNELYE · KantarHealth - France
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
More Related Trials
-
Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy
NCT01888575 ·Status: COMPLETED
-
EffectiveNess of Low-dose Aspirin in Prevention of Cancer in the Stomach and Oesophagus (GastrointEstinal Cancer Prevention) - United Kingdom ("ENgAGE - UK"): Study to Evaluate the Risk of Cancer in the Stomach and Oesophagus Among New Users of Low-dose Aspirin Using the THIN Database in the UK
NCT03743883 ·Status: COMPLETED
-
The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
NCT01814943 ·Status: COMPLETED
-
Risk of Uncomplicated Peptic Ulcer in the General Population
NCT01888588 ·Status: COMPLETED
-
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
NCT01104441 ·Status: COMPLETED
-
Duration of Platelet Inhibition by Aspirin
NCT00671021 ·Status: COMPLETED
-
Aspirin in Reducing Events in the Elderly
NCT01038583 ·Status: UNKNOWN
-
Aspirin Resistance in Coronary Artery Disease
NCT00753935 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
NCT04586972 ·Status: COMPLETED
-
Improving Aspirin Use Among Adults at Risk for Cardiovascular Disease (CVD)
NCT00981032 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Probiotic Strain on Aspirin-induced GI Damage.
NCT03228589 ·Status: COMPLETED ·Phase: PHASE2
-
Compliance in the Physicians' Health Study
NCT00005404 ·Status: COMPLETED
-
Aspirin Responsiveness in Women With Coronary Artery Disease
NCT01406990 ·Status: COMPLETED
-
Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
NCT00222261 ·Status: COMPLETED ·Phase: PHASE4
-
ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
NCT04912505 ·Status: COMPLETED ·Phase: PHASE2
-
TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular Disease
NCT04132791 ·Status: TERMINATED ·Phase: NA
-
Timed Aspirin Chronobiome Study
NCT03590821 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Clinical Study Evaluating the Gastroprotective Effect of Carvedilol in Patients With Ischemic Heart Disease on Aspirin Therapy
NCT05553717 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease
NCT04217447 ·Status: TERMINATED ·Phase: PHASE3
-
Japanese Primary Prevention Project With Aspirin
NCT00225849 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
NCT02960126 ·Status: UNKNOWN ·Phase: PHASE3
-
Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg
NCT01669824 ·Status: COMPLETED
-
An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel
NCT01210339 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular Disease
NCT03757156 ·Status: UNKNOWN ·Phase: NA
-
Appropriateness of Aspirin Use in Medical Outpatients
NCT03387384 ·Status: UNKNOWN